• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Evonik

    FDA Approves Sobi`s NASP Biologics License for Uncontrolled Gout

    PR NEWSWIRE

    Sobi and Selecta announce completion of enrolment in Phase 3 study of SEL-212

    BIOSPACE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.